Major Design Experience - Professionalism

Jan founded Arboretum Ventures on the premise that innovation is key to delivering value in healthcare, a principle she developed working in the medical device industry for over two decades. Her investments focus on promising medical technologies that enable meaningful healthcare system savings while maintaining great clinical outcomes. Jan has led and held board seats in more than a dozen investments across four funds including notable exits with HandyLab, Esperion (Nasdaq: ESPR), CardioMEMS, nVision and NxThera.

Prior to co-founding Arboretum, Jan spent 20 years in entrepreneurial healthcare companies. She was previously President & Founder of Strategic Marketing Consultants advising healthcare start-ups and major medical device companies. Jan also held key management roles in marketing, clinical research, and sales for two successful medical device start-ups, Advanced Cardiovascular Systems and Devices for Vascular Intervention. Each of these companies was acquired by Eli Lilly and became the foundation for Guidant Corporation. Earlier in her career, Jan was an engineer and product manager for Procter & Gamble.

Jan is currently serving as Board Chair of the National Venture Capital Association (NVCA) and has been a member of the Board of Directors since 2015. Jan has been recognized as the 2015 Crain’s Newsmaker of the Year and as one of Crain’s Most Influential Women in 2016. She earned a BS in Bioengineering from the University of California at Berkeley and an MBA from the Wharton School at the University of Pennsylvania.

Andrea has been doing financial management for most of her life. She started in the field by providing investment reports for her family at the age of 12. In college, she sold oil and gas contracts. After graduating from college, she was the securities coordinator nationally for Capital Resource Group out of Orlando Florida. Andrea came back to Michigan for a position with Charles Schwab as a Vice President and Financial Consultant. At the age of 28, she left Charles Schwab to become an independent advisor. She was ready to change the industry. She did not like what she saw in the big companies and believed her clients deserved better. By the age of 32, she was a partner with Chisholm & Dames Investment Advisors, later Chisholm & Darden Investment Advisors and now C&D Wealth Advisors. At the age of 39, Andrea founded Darden Wealth Group.

Currently, Andrea oversees all firm activities and strategies and is responsible for all the wealth and financial plans for the firm’s clients.

Previously in her spare time, Andrea was a lecturer of Financial Planning at Olivet College teaching many of the CFP® or Certified Financial Planning courses. Andrea holds the AAMS (Accredited Asset Management Certification). She went to Stetson University on a basketball scholarship, later winning two National Championships as a semi-pro basketball player. She has a passion for helping businesses and families reach their financial goals.

Andrea is married to Prof. Marcus Darden who teaches Computer Science at the University of Michigan. They have two children, Catherine, and Marcus, Jr. In Prof. Darden’s spare time you can find him playing saxophone with the band, Global Village, who has opened for such big names as Smokey Robinson, Journey, SmashMouth, and more.

Professor Kuipers will discuss ethical issues of deploying AI technology, and we will have small group discussions on hypothetical decisions you may face in your careers.

Benjamin Kuipers is a Professor of Computer Science and Engineering at the University of Michigan. He was previously an endowed Professor in Computer Sciences at the University of Texas at Austin, where he served as Department Chair. He received his B.A. from Swarthmore College, his Ph.D. from MIT, and he is a Fellow of AAAI, IEEE, and AAAS.

His research in artificial intelligence and robotics focuses on the representation, learning, and use of foundational domains of knowledge, including knowledge of space, dynamical change, objects, and actions. He is currently investigating ethics as a foundational domain of knowledge for robots and other AIs that may act as members of human society.

In this talk, I will argue that the problem is much larger than these (important) technical issues. To do so, I will examine some of the regulatory structures, processes, definitions, rules, and conventions that have been developed by the US Food and Drug Administration (FDA). I will draw heavily from two separate scenarios: the FDA’s regulation of pharmaceuticals and their regulation of medical devices. The elaborate processes set up to regulate the drug and medical device industries have been remarkably successful (in many ways), and I will argue that many of the structures in place there deserve analogous systems for the regulation of face recognition.

Erik Learned-Miller is a Professor in the College of Information and Computer Sciences, at the University of Massachusetts, Amherst, where he joined the faculty in 2004. His research interests include face recognition, unsupervised learning and learning from small training sets, vision for robotics, and motion understanding. He spent two years as a post-doctoral researcher at the University of California, Berkeley, in the Computer Science Division. Learned-Miller received a B.A. in Psychology from Yale University in 1988. In 1989, he co-founded CORITechs, Inc., where he co-developed the second FDA cleared system for image-guided neurosurgery. He worked for Nomos Corporation, Pittsburgh, PA, for two years as the manager of neurosurgical product engineering. He obtained Master of Science (1997) and Ph. D. (2002) degrees from the Massachusetts Institute of Technology, both in Electrical Engineering and Computer Science. In 2006, he received an NSF CAREER award for his work in computer vision and machine learning. He was a co-Program Chair for CVPR 2015 in Boston.